REFERENCES
- Matricardi PM, Dal Negro RW, Nisini R. The first, holistic
immunological model of COVID-19: implications for prevention,
diagnosis, and public health measures. Pediatr Allergy Immunol 2020
May 2. doi: 10.1111/pai.13271.
- Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives
on the regulation of innate and adaptive immunity. Nat Clin Pract
Endocrinol Metab 2008;4:80-90.
- Mirijello A, Tosoni A, Zaccone V, Impagnatiello M, Passaro G, Vallone
CV, et al. MEDS score and vitamin D status are independent predictors
of mortality in a cohort of Internal Medicine patients with
microbiological identified sepsis. Eur Rev Med Pharmacol Sci
2019;23:4033-4043.
- Li Y, Ding S. Serum 25-Hydroxyvitamin D and the risk of mortality in
adult patients with Sepsis: a meta-analysis. BMC Infect Dis
2020;20:189.
- Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL,
et al. Evidence that Vitamin D Supplementation Could Reduce Risk of
Influenza and COVID-19 Infections and Deaths. Nutrients 2020;12. pii:
E988. doi: 10.3390/nu12040988.
- Marik PE, Kory P, Varon J. Does vitamin D status impact mortality from
SARS-CoV-2 infection? Med Drug Discov 2020 Apr 29:100041. doi:
10.1016/j.medidd.2020.100041.
- Silberstein M. Vitamin D: A simpler alternative to tocilizumab for
trial in COVID-19? Med Hypotheses 2020;140:109767. doi:
10.1016/j.mehy.2020.109767.